Nur Syafiqah Mohamad Ishak

Dr. Nur Syafiqah Mohamad Ishak

Niigata Research Laboratory, Mitsubishi Gas Chemical (Japan), Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
NINur Syafiqah Mohamad Ishak
Nur Syafiqah Mohamad Ishak
QNQuang Dang Nong
Quang Dang Nong
TMTomoaki Matsuura
Tomoaki Matsuura
YKYasuhiko Kato
Yasuhiko Kato
HWHajime Watanabe
Hajime Watanabe
Divergence of upstream regulatory pathways of the transcription factor Doublesex (Dsx) serves as a basis for evolution of sex-determining mechanisms in animals. However, little is known about the regulation of Dsx in environmental sex determination. In the crustacean Daphnia magna, environmental sex determination is implemented by male-specific expression of the Dsx ortholog, Dsx1. Transcriptional regulation of Dsx1 comprises at least three phases during embryogenesis: non-sex-specific initiation, male-specific up-regulation, and its maintenance. Herein, we demonstrate that the male-specific up-regulation is controlled by the bZIP transcription factor, Vrille (Vri), an ortholog of the circadian clock genes—Drosophila Vri and mammalian E4BP4/NFIL3. Sequence analysis of the Dsx1 promoter/enhancer revealed a conserved element among two Daphnia species (D. magna and D. pulex), which contains a potential enhancer harboring a consensus Vri binding site overlapped with a consensus Dsx binding site. Besides non-sex-specific expression of Vri in late embryos, we found male-specific expression in early gastrula before the Dsx1 up-regulation phase begins. Knockdown of Vri in male embryos showed reduction of Dsx1 expression. In addition, transient overexpression of Vri in early female embryos up-regulated the expression of Dsx1 and induced male-specific trait. Targeted mutagenesis using CRISPR/Cas9 disrupted the enhancer on genome in males, which led to the reduction of Dsx1 expression. These results indicate that Vri was co-opted as a transcriptional activator of Dsx1 in environmental sex determination of D. magna. The data suggests the remarkably plastic nature of gene regulatory network in sex determination. Sex is widespread for reproduction of offspring in the animal kingdom. In the sex determination process, through interactions of several genes in a hierarchical manner, an initial cue leads to sex-specific expression of the major effector of sexual differentiation, Doublesex (Dsx). Although how genetic factors on sex chromosomes control Dsx expression has been extensively studied in model organisms such as mouse, fruit fly, and nematodes, little is known about dependence of Dsx regulation on environmental signals. We used the crustacean, Daphnia magna, owing to its advantages for analyzing environmental sex determination: 1) fully sequenced genome, 2) recent advancement of genome engineering and 3) artificial control of sex by juvenile hormone treatment. We found that early male embryos transiently express the bZIP transcription factor, Vrille (Vri), known to be a circadian regulator, before male-specific Dsx1 activation begins. Disruption of a potential Vri-binding site in the Dsx1 regulatory region, and gain- and loss-of-function analyses revealed that Vri regulates male-specific Dsx1 activation in Daphnia. We infer that a novel gene can be co-opted as a regulator of Dsx in environmental sex-determining pathway. Our results would expand our understanding about the diversity and evolution of the sex-determining pathways in animals.

29 February 2024 in Frontiers in Aging
Verified
Journal Article
Open access
NINur Syafiqah Mohamad Ishak
Nur Syafiqah Mohamad Ishak
MKMidori Kikuchi
Midori Kikuchi
KIKazuto Ikemoto
Kazuto Ikemoto
Background: Understanding and promoting healthy aging has become a necessity in the modern world, where life expectancy is rising. The prospective benefits of the antioxidant pyrroloquinoline quinone (PQQ) in healthy aging are promising. However, its role in aging remains unclear. Thus, this study aimed to investigate the effect of PQQ on preventing the progression of aging and to explore its underlying molecular mechanisms.Methods: Naturally aged C57BL/6J male mice were fed a normal diet with or without PQQ (20 mg/kg/day) for 10 weeks. Body composition was measured by bioimpedance at weeks 0 and 8. The integument conditions were evaluated at weeks 0, 4, and 8. Muscle strength and function were examined at week 8. At the ninth week, computed tomography images of the mice were captured, and blood and tissue samples were collected. The levels of inflammatory cytokines in the gastrocnemius muscle were measured, and the muscle fiber cross-sectional area in the soleus muscle was examined. Additionally, a D-galactose (D-gal)-induced cell aging model was used to study the effects of PQQ intervention on cell proliferation, senescence, differentiation, ROS levels, and mitochondrial function in myoblasts (C2C12). Cell proliferation and monolayer permeability of D-gal-induced intestinal epithelial cells (IEC6) were also examined.Results: Aged mice suffered from malnutrition; however, PQQ supplementation ameliorated this effect, possibly by improving metabolic dysfunction and small intestinal performance. PQQ prevented rapid loss of body fat and body fluid accumulation, attenuated muscle atrophy and weakening, reduced chronic inflammation in skeletal muscles, and improved skin and coating conditions in aged mice. Furthermore, PQQ intervention in D-gal-treated C2C12 cells improved mitochondrial function, reduced cellular reactive oxygen species (ROS) levels and senescence, and enhanced cell differentiation, consequently preventing age-related muscle atrophy. In addition, PQQ increased cell proliferation in D-gal-treated IEC6 cells and consequently improved intestinal barrier function.Conclusion: PQQ could hinder the aging process and particularly attenuate muscle atrophy, and muscle weakness by improving mitochondrial function, leading to reduced age-related oxidative stress and inflammation in muscles. PQQ may also ameliorate malnutrition caused by intestinal barrier dysfunction by enhancing IEC proliferation. This study provides evidence for the role of PQQ in aging and suggests that PQQ may be a potential nutritional supplementation that can be included in healthy aging strategies.

30 September 2025 in Processes
Verified
Journal Article
Open access
PDF file
TKTomoyo Koshizawa
Tomoyo Koshizawa
TNTomoe Numaguchi
Tomoe Numaguchi
MTMasanori Tamakoshi
Masanori Tamakoshi
YSYuuki Sato
Yuuki Sato
KHKatsuyuki Hashimoto
Katsuyuki Hashimoto
KIKazuto Ikemoto
Kazuto Ikemoto
Polyamines, particularly spermidine, have emerged as key dietary factors with roles in cellular health, autophagy, and longevity. However, strategies for scalable production of polyamine-rich food ingredients remain limited. Here, we report the development of a high-spermidine-producing Saccharomyces cerevisiae strain, 3L63, obtained via ultraviolet mutagenesis of the K7 strain. This strain exhibited a 5.9-fold increase in the total polyamine content, with spermidine being the most abundant. A scalable fermentation system of up to 104 L was established, yielding a dried yeast product that met food safety criteria. Whole-genome sequencing identified mutations in central metabolic pathways, including ARG3, and functional enrichment analysis suggested broad metabolic rewiring, supporting an enhanced biosynthetic capacity, including polyamines. Free amino acid profiling revealed higher arginine levels in 3L63 than in K7, which is consistent with its role as a polyamine precursor. The 3L63 yeast-derived product was enriched in essential amino acids and polyamines. Functionally, this strain promoted the proliferation of normal and senescent human dermal fibroblasts, and its autophagy-inducing activity exceeded that of equivalent concentrations of pure spermidine, suggesting synergistic effects of yeast-derived bioactive compounds. This study demonstrates a non-genetically modified, high-spermidine yeast strain as a promising functional food ingredient with potential applications in healthy aging.

13 November 2023 in ACS Omega
Verified
Journal Article
Open access
NINur Syafiqah Mohamad Ishak
Nur Syafiqah Mohamad Ishak
TNTomoe Numaguchi
Tomoe Numaguchi
KIKazuto Ikemoto
Kazuto Ikemoto
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) is ongoing. Therefore, effective prevention of virus infection is required. Pyrroloquinoline quinone (PQQ), a natural compound found in various foods and human breast milk, plays a role in various physiological processes and is associated with health benefits. In this study, we aimed to determine the effects of PQQ on preventing coronavirus infections using a proxy Feline Infectious Peritonitis Virus (FIPV; belongs to the coronavirus family). In plaque reduction assays, we showed that pre- and post-PQQ-treated viruses were less infectious. IC50 was 87.9 and 5.1 μM for pre- and post-PQQ-treated viral infections, respectively. These results suggest that PQQ decreased the virion stability and viral replication. RT-qPCR confirmed these results. TEM findings showed that PQQ damaged viral capsids and aggregated viral particles, leading to inhibited virus attachment and entry into the host cells. PQQ was optimized by the addition of ascorbic acid and glutamic acid, which increased the number of redox cycles of PQQ and increased reactive oxygen species production by 14 times. In vitro, PQQ inhibited 3 CLpro/Mpro enzymes (an enzyme critical for viral replication) activity of SARS-CoV-2. Our results demonstrate the antiviral effect of PQQ on coronavirus, mainly by disrupting virion stability and loss of infectivity (occurring outside the host cell), due to increased redox activity. Furthermore, PQQ may hinder viral replication (inside the host cell) by 3 CLpro/Mpro enzyme inhibition. In summary, this study demonstrates the antiviral effect of PQQ and its potential application in coronavirus diseases.

26 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
TKTomoyo Koshizawa
Tomoyo Koshizawa
TNTomoe Numaguchi
Tomoe Numaguchi
MTMasanori Tamakoshi
Masanori Tamakoshi
YSYuuki Sato
Yuuki Sato
KHKatsuyuki Hashimoto
Katsuyuki Hashimoto
KIKazuto Ikemoto
Kazuto Ikemoto
Polyamines, particularly spermidine, have emerged as key dietary factors with roles in cellular health, autophagy, and longevity. However, strategies for scalable production of polyamine-rich food ingredients remain limited. Here, we report the development of a high-spermidine-producing Saccharomyces cerevisiae strain, 3L63, obtained via ultraviolet mutagenesis of the K7 strain. This strain exhibited a 5.9-fold increase in the total polyamine content, with spermidine being the most abundant. A scalable fermentation system of up to 104 L was established, yielding a dried yeast product that met food safety criteria. Whole-genome sequencing identified mutations in central metabolic pathways, including ARG3, and functional enrichment analysis suggested broad metabolic rewiring, supporting an enhanced biosynthetic capacity, including polyamines. Free amino acid profiling revealed higher arginine levels in 3L63 than in K7, which is consistent with its role as a polyamine precursor. The 3L63 yeast-derived product was enriched in essential amino acids and polyamines. Functionally, this strain promoted the proliferation of normal and senescent human dermal fibroblasts, and its autophagy-inducing activity exceeded that of equivalent concentrations of pure spermidine, suggesting synergistic effects of yeast-derived bioactive compounds. This study demonstrates a non-genetically modified, high-spermidine yeast strain as a promising functional food ingredient with potential applications in healthy aging.

15 May 2026 in Frontiers in Aging
Verified
Journal Article
Open access
PDF file
TNTomoe Numaguchi
Tomoe Numaguchi
MNMai Nakamura
Mai Nakamura
TKTomoyo Koshizawa
Tomoyo Koshizawa
NINur Syafiqah Mohamad Ishak
Nur Syafiqah Mohamad Ishak
KHKatsuyuki Hashimoto
Katsuyuki Hashimoto
Background: Aging is a multifaceted biological process driven by interconnected cellular and molecular hallmarks. As geroscience increasingly prioritizes healthspan over lifespan, nutritional interventions targeting multiple aging mechanisms have gained attention as accessible strategies to mitigate age-related functional decline. Objective: This mini review synthesizes recent evidence on how the bioactivities of two food-derived geroprotective compounds, pyrroloquinoline quinone (PQQ) and spermidine (SPD), intersect with the hallmarks of aging and their distinct and overlapping roles in maintaining cellular homeostasis. Findings: PQQ primarily functions as a mitochondrial and redox regulator, enhancing mitochondrial biogenesis and bioenergetic capacity through the AMP-activated protein kinase (AMPK) and sirtuin1 (SIRT1)/peroxisome proliferator-activated receptor gamma coactivator 1-alpha pathways. In contrast, SPD acts as a key regulator of cellular quality control by inducing macroautophagy and preserving proteostasis, largely through modulation of histone and autophagy-related protein acetylation. These complementary mechanisms converge on several key hallmarks of aging, including genomic instability, deregulated nutrient sensing, mitochondrial dysfunction, and chronic inflammation. Conclusion: The anti-aging mechanisms of PQQ and SPD originate from distinct upstream biochemical processes but converge on shared signaling hubs, including the AMPK/SIRT1 axis and autophagy-related networks. This convergence suggests a coordinated network-level complementarity that may offer a more robust intervention against age-related decline than targeting independent pathways alone.